Effect of topotecan on serum CA-125 in patients with paclitaxel - and platinum-resistant, advanced epithelial ovarian cancer

被引：0
|
作者：
Nielsen, H
Nielsen, D
Aa, S
机构：
[1] Copenhagen Univ Hosp, Dept Oncol, Finsen Ctr, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Finsen Ctr, Dept Oncol, Copenhagen, Denmark
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
347P
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Effect of topotecan on serum CA-125 in patients with advanced epithelial ovarian cancer
    Nielsen, HA
    Nielsen, D
    Engelholm, SA
    GYNECOLOGIC ONCOLOGY, 2000, 77 (03) : 383 - 388
  • [2] Topotecan in platinum-resistant epithelial ovarian cancer
    Karabulut, B
    Sezgin, C
    Terek, MC
    Uslu, R
    Sanli, UA
    Akman, L
    Ozsaran, A
    Dikmen, Y
    Goker, E
    CHEMOTHERAPY, 2005, 51 (06) : 347 - 351
  • [3] Paclitaxel in platinum-resistant ovarian cancer patients
    Ezcurdia, L
    Jovtis, SL
    Mickiewicz, E
    Temperley, G
    Rondinon, M
    Blajman, C
    Coppola, FS
    Lewi, D
    Cazap, E
    Breier, S
    Fasce, H
    Fein, L
    Polera, J
    Triguboff, E
    Uranga, G
    Pasccon, G
    Luchina, AM
    Martinez, CA
    Politi, PM
    Rubio, G
    Alvarez, AM
    SEMINARS IN ONCOLOGY, 1997, 24 (05) : 53 - 56
  • [4] Salvage chemotherapy with paclitaxel in platinum-resistant advanced ovarian cancer patients
    Bruzzone, M
    Catsafados, E
    Miglietta, L
    Amoroso, D
    Pedulla, F
    Giannessi, PG
    Locatelli, MC
    DAntona, A
    Foglia, G
    Mammoliti, S
    Turno, F
    Gentile, A
    Nicosia, F
    Luporini, G
    Ragni, N
    Boccardo, F
    ONCOLOGY, 1996, 53 (05) : 349 - 353
  • [5] Effects of paclitaxel on CA-125 serum levels in ovarian cancer patients
    Paulsen, T
    Marth, C
    Kærn, J
    Nustad, K
    Kristensen, GB
    Tropé, C
    GYNECOLOGIC ONCOLOGY, 2000, 76 (03) : 326 - 330
  • [6] Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel
    Bridgewater, JA
    Nelstrop, AE
    Rustin, GJS
    Gore, ME
    McGuire, WP
    Hoskins, WJ
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 501 - 508
  • [7] Paclitaxel in platinum-resistant epithelial ovarian carcinoma
    Wardley, AM
    Jenkins, A
    Alison, DL
    Perren, TJ
    BRITISH JOURNAL OF CANCER, 2000, 83 : 79 - 79
  • [8] Effect of low-dose oral etoposide on serum CA-125 in patients with advanced epithelial ovarian cancer
    deJong, RS
    Hofstra, LS
    Willemse, PHB
    deBruijn, HWA
    deVries, EGE
    Boonstra, H
    Mulder, NH
    GYNECOLOGIC ONCOLOGY, 1997, 66 (02) : 197 - 201
  • [9] Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
    Rustin, G. J. S.
    Hall, M. R.
    ANNALS OF ONCOLOGY, 2016, 27 (08) : 1365 - 1366
  • [10] A phase I trial of topotecan and sorafenib for patients with recurrent, platinum-resistant epithelial ovarian cancer
    Matei, Daniela E.
    Schilder, Jeanne
    Perkins, Susan
    Khan, Mohammad
    Calley, Cynthia
    Menning, Nancy
    Sutton, Gregory
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
12345